Phase 2b/3 Alzheimer's trial enrolment passes 50% - twenty US trial sites continuing to recruit par...
All 20 US trial sites are now open in the XanaMIA phase 2b/3 trial that is studying oral Xanamem® v...
Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: * Wi...
Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical t...
Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026 SYDNEY, ...
* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * App...
Durable benefits previously reported for the MADRS depression scale are supported by the patient-re...
There was a clinically meaningful and persistent improvement depression measured by the key seconda...
The prospectively defined, double-blind analysis of biomarker-positive patients with mild Alzheimer...
Trial results anticipated in early Q3 this year SYDNEY, April 22, 2024 /PRNewswire/ -- Actinogen Me...
Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the In...
The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue cortisol synthesis enz...
US$3.2 million (A$4.8m) R&D tax incentive rebate received from Australian Tax Office and XanaMIA Ph...
Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising s...
Highlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years a...
Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising s...
A longitudinal dataset indicating the utility of plasma pTau for patient selection in clinical tria...
Exploring Xanamem® and the "cortisol hypothesis" for more than 6 million Americans suffering from A...
Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1] which is commonly ass...
Clinical Dementia Rating Scale - Sum of Boxes effect of 0.6 to 0.8 points observed in patients with...